# A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate

> **NCT00620685** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 27 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Placebo
- **DRUG:** PH-797804
- **DRUG:** PH-797804

## Key facts

- **NCT ID:** NCT00620685
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620685, "A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT00620685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*